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Abstract
Background: The pathophysiological overlapping between Sjorgen’s Syndrome (SS) and HCV, presence of anti-
muscarinic receptor type 3 (M3R) antibodies in SS, the role that M3R plays in the regulation of the heart rate, has
led to the assumption that cardiovagal dysfunction in HCV patients is caused by anti-M3R antibodies elicited by
HCV proteins or by their direct interaction with M3R.
Results: To identify HCV protein which possibly is crossreactive with M3R or which binds to this receptor, we
performed the Informational Spectrum Method (ISM) analysis of the HCV proteome. This analysis revealed that
NS5A protein represents the most probable interactor of M3R or that this viral protein could elicit antibodies which
modulate function of this receptor. Further detailed structure/function analysis of NS5A and M3R performed by the
ISM method extended with other Digital Signal processing (DSP) approaches revealed domains of these proteins
which participate in their crossreactivity or in their direct interaction, representing promising diagnostic and
therapeutic targets.
Conclusions: Application of the ISM with other compatible bioinformatics methods offers new perspectives for
identifying diagnostic and therapeutic targets for complicated forms of HCV and other viral infections. We show
how the electron-ion interaction potential (EIIP) amino-acid scale used in the ISM combined with a robust, high
performance hydrophobicity scale can provide new insights for understanding protein structure/function and
protein-protein interactions.
Keywords: Informational Spectrum Method, Hepatitis C, Muscarinic receptor type 3, Cross-reactivity, Autonomic
nervous system, EIIP, Hydrophobicity
Background
The problem of understanding protein structure, func-
tion and binding epitopes from the sequence remains
challenging. In this paper, we extended the ISM, [1, 2]
that combines an Electron Ion Interaction Potential
(EIIP) amino acid scale, with a high performance hydro-
phobicity scale along with a novel DFT algorithm [3].
We show that ISM extended with other Digital Signal
processing (DSP) approaches provides a unique way to
understand the formation of protein domains and rela-
tion of primary sequence to the formation of secondary
structure and the location of epitopes. We have used this
method to understand virus-induced autoimmune
diseases.
Lymphoproliferative disorders usually accompany per-
sistent hepatitis C virus (HCV) infection [4]. This leads
to a number of extra-hepatic manifestations [5] one of
them being the Sjögren’s syndrome (SS). This syndrome,
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characterized by the kerato-conjuctivitis sicca and xeros-
tomia, was proven to be associated with the presence of
autoantibodies for the muscarinic receptor type 3
(M3R). The association was confirmed both in the pri-
mary and secondary forms of this syndrome [6–8].
Anti-muscarinic antibodies have been found to be cru-
cial for exocrine gland dysfunction [6], but also for other
accompanying autonomic dysfunctions (sudomotor,
cardio-vagal and adrenergic functions) [9]. This import-
ant pathophysiological overlap between SS and HCV is
further supported by data on cardio-vagal dysfunction in
HCV [10–12]. Cardio-vagal dysfunction [13–18] is iden-
tified as one of the main reasons for increased mortality
in chronic liver disease [19].
The mechanism of cardio-vagal lesion in HCV is still
unknown. Some hypotheses have been proposed, like an
immune mediated, common pathophysiological mechan-
ism of hepatocellular damage and cardiac autonomic
dysfunction [11, 12].
The acetylcholine muscarinic type 3 receptor (M3R), a
G protein coupled receptor (GPCR), participates in the
regulation of the heart rate and cardiac repolarization in
animals [20] and humans [18, 21, 22]. Molecular signal-
ing pathways participating in cardiac parasympathetic
regulation, which include M3R, are still elusive, although
some possible mechanisms have been proposed [23].
In addition to the heart, M3Rs are also present on pro-
genitor hepatic cells [24]. This pool of cells is of particular
importance for the regenerative process in diseased livers,
including chronic HCV infection. Vagal stimulation, medi-
ated through M3R, is therefore of crucial importance by
increasing the pool of hepatocyte progenitor cells [24].
Since the M3R participates both in the regulation of
the heart rate [20, 22], and hepatocyte turnover [23, 24],
we hypothesize that the part of the possible common
mechanism of the lesion of cardiac parasympathetic
regulation and hepatocyte compartment [11, 12] is
through immune-modulatory autoantibodies to M3R.
A number of studies have investigated the potential
role of molecular mimicry in autoimmune disorders as-
sociated with HCV infection [25–27]. It is interesting to
note that immunological cross-reactivity between
proteins has been shown to correspond to a common
frequency component in their informational spectra (IS)
[28–31]. Our objective in this work was therefore to
look for a common frequency in the IS (Information
Spectrum) of M3R and the HCV proteins allowing us to
provide strong evidence that the cross-reactivity is in-
deed due to molecular mimicry. We performed an ISM
analysis of all proteins from the EUHCV database. Our
analysis showed that the NS5A protein, particularly from
HCV viruses genotype 1b, represents the most probable
antigen which is cross-reactive with M3R. We also
mapped a domain and binding epitope of NS5A
representing a potential prognostic and therapeutic tar-
get for the cardiac dysfunction caused by the HCV virus.
Methods
Datasets
The dataset was created by extracting only the comple-
te—full length HCV protein sequences from the GenBank
polyprotein sequences. Human muscarinic acetylcholine
receptor M3 was retrieved from UniProtKB/Swiss-Prot
with accession number P20309. Prototype HCV protein
sequences were retrieved from the EUHCV database [32].
Informational spectrum method (ISM)
The ISM starts by assigning a numerical value to each
amino acid in the sequence that best represents the
physico-chemical property of the amino acid involved in
the structure and biological activity of the protein. In
this paper, we have used two different, but related
methods to assign numerical values to each of the amino
acids in the primary sequence—one is the electron-ion
interaction potential (EIIP) [33–38], and the other is
from a hydrophobic proclivity scale [3]. The next step in
the ISM is to apply a Discrete Fourier Transform (DFT)
and transform the protein primary (“time signal”) se-
quence into the frequency domain. In analyzing protein
sequences, the relevant information is presented as an
energy density spectrum (review in Reference 39) from
the square of the Fourier Transform derived frequency
amplitude coefficients obtained from the numerically
encoded amino-acid sequence. The information defined
by the sequence of amino acids is then available as an
Information Spectrum (IS) representing a series of fre-
quencies and their amplitudes. The total number of fre-
quencies represented by the DFT amplitude/phase
coefficients is limited by the Nyquist sampling theorem
from information theory and the mathematics of the
DFT algorithm. Each amino acid in the primary
sequence is “sampled” at some “equal” frequency corre-
sponding to the “time” intervals of one inter-amino acid
step in the primary sequence. Due to the time and fre-
quency symmetry, the reciprocal of each frequency f(n)
from the DFT corresponds to a correlation of some step
distance d(n) = 1/f(n) between amino acids in units of
one amino-acid step distance. Per the Nyquist theorem,
the maximum frequency (f(n =N)) will always be 0.5
corresponding to resolving a minimum inter-amino acid
correlation distance of 2.0 amino-acids.
The IS frequencies f(n) corresponds to the distribution
of structural motifs with defined physico-chemical char-
acteristics responsible for the biological function of a
protein and its binding affinities. Similarly, the amino-
acid correlation distances d(n) provide information
about the secondary and tertiary structure of the sam-
pled protein, and about binding epitopes within proteins
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associated with long range inter-molecular attraction
and binding. When comparing proteins which share the
same biological or biochemical function, the ISM tech-
nique allows detection of protein-protein correlation
pairs, whose common frequency amplitudes f(n) are spe-
cific for their common biological properties, or which
correlate with their specific interaction. These common,
dominant informational characteristic frequencies of the
protein sequences are determined/pin-pointed by a
Cross-spectrum or Consensus Informational Spectrum
(CIS) (i.e. the Fourier transform of the auto-correlation
function for the spectrum). In this way, any spectral
component (frequency) not prominent in all compared
IS spectrum’s are diminished and thereby eliminated. If
one calculates a CIS (by multiplication of all the power
spectrum values together at each corresponding fre-
quency for each protein power spectrum) for a group of
proteins having different primary structures, and finds
strictly defined peak frequencies, it means that the ana-
lyzed proteins participate in mutual interactions or have
a common biological functions.
We show in this paper how the ISM algorithm com-
bines the method’s native EIIP scale with a robust hydro-
phobicity scale to provide a unique understanding into
protein domains, functions and binding epitopes.
The hydrophobicity scale
Hydrophobicity is a primary physico-chemical property of
amino-acids associated with the structure and function of
proteins. Hydrophobicity is a real and measurable force
between aqueous clathrate membranes that spontaneously
form about hydrophobic surfaces; a force which can oper-
ate up to 100-200nm [39–41]. Since there is a range of
amino-acid physico-chemical properties with respect to
each other and with respect to water, a hydrophobicity
scale must reflect continuum differences ranging between
extremes of molecular size, mass, geometry, polarity/
hydrophilicity and molecular non-polarity/hydrophobicity.
Amino-acid hydrophobicity scales (with various draw-
backs/defects) have proliferated in the literature, but ef-
fectively they measure the contrast of the strength of
interaction between amino-acids and water as a means of
devising an amino-acid scale/index. The hydrophobicity
scale used in this study has been developed to overcome
current literature amino-acid hydrophobicity scale limita-
tions in order to more accurately reflect the central, net
resultant of amino-acid physico-chemical properties
which result in amino-acid hydrophobicity’s (e.g. their
interaction potentials with water) [3].
The EIIP scale
The EIIP scale reflects the average energy of atomic
valence shells and the resulting molecular orbitals of
each amino-acid, acting as discrete electronic units,
building up the electronic properties of peptides and
proteins. The EIIP scale therefore reflects molecular
properties from delocalized electron density. It is this
latter property that allows proteins to have motifs
with distinct wavelengths that support functions es-
sential to specific protein functions and long range
protein attractions [1, 2].
The joint dependencies (i.e. in phase relationships) of
amino-acid EIIP and hydrophobicity properties reflect
important functional epitopes or structural motifs within
proteins, as we show in this current study. We postulate
that the EIIP scale reflects the proclivity of a protein to
form a QM/EM dipole capable of long range (up to 200
nm) attractions between proteins or proteins-substrates.
Furthermore, we hypothesize that the inter-molecular
QM/EM dipole interaction is transduced by aqueous
clathrate shells (reflected by the hydrophobicity scale) at
appropriate locations and transmitted through the bulk
waters as a polaron mediated by aqueous phonons that
operate in the low Terahertz frequency region.
The ISM algorithmic steps for generating an informational
spectrum analysis
1. Convert a protein sequence into its numerical
sequences with EIIP and hydrophobicity index
values
2. Apply the discrete Fourier transformation to the
resulting two numerical series to generate the power
density spectrum.
3. Apply the Cross Informational Spectrum algorithm
(i.e. multiply the corresponding frequency
amplitudes squared) to the set of DFT spectral
energies and obtain the CIS consensus spectrum to
recover the dominant relational/inter-correlation
frequency/frequencies.
4. Perform the sliding window DFT algorithm
calculating signal to noise (S/N) calculations for
each window location for each of the dominant CIS
frequencies to identify the hot spot location(s) for
each protein corresponding to binding epitopes/
active sites being indicated by the ISM method.
5. For the hybrid algorithm introduced in this paper,
for each protein run the Cross-Correlatoin Depen-
dancy (CCD) analysis on the product of the EIIP
encoded sequence and the hydrophobicity encoded
sequence in order to recover the primary binding
epitopes and confirm the conventional ISM hot spot
locations.
Core equations describing the discrete fourier transform
(DFT)
The protein primary sequence, which has been numeric-
ally encoded into a number sequence representing the
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alternate numerical description of a protein, is processed
with the Discrete Fourier Transformation (DFT) defined
according to the following equations:
X nð Þ ¼
XN
m¼1
x mð Þe−i2πnm=N ; n ¼ 1; 2;…;N=2 ð1Þ
where m is the summation index, x(m) is the mth
member of a given numerical “signal” series (from a
transformed, encoded primary protein sequence in our
case), N is the total number of points in this series (in
our case the number of amino-acids), n is the number of
a discrete frequency (ranging from 1 on up to N/2) in
the DFT, X(n) are the discrete Fourier transformation
amplitude coefficients corresponding to each discrete
frequency n, and 2π*(n/N) is the phase angle at each
given m in the amino-acid series of the protein in ques-
tion. These X(n) amplitude coefficients and correspond-
ing Y(n) phase coefficients describe the amplitude, phase
and frequency of sinusoids, which are a frequency based
decomposition of the signal, that both describe the
original protein signal and can be used to reconstitute/
recover the original signal. The complex discrete Fourier
transformation defines both the amplitude spectrum and
the phase spectrum, where the complete information
about the original sequence is contained between both
spectral functions. However, in the case of protein ana-
lysis, the relevant information is primarily presented in
energy density spectrum (for review see [42]), which is
defined as follows:
S nð Þ ¼ X nð ÞX nð Þ ¼ X nð Þj j2; n ¼ 1; 2;…;N=2 ð2Þ
Cross-codependency (EIIP, hydrophobicity) DFT analysis
A modified version of the ISM DFT algorithm using the
Euler formula was also used on a derivative metric cal-
culated by multiplying each given protein amino-acid
hydrophobicity times its corresponding EIIP value. This
secondary metric will reflect the joint biophysical effects
of amino-acid molecular orbital electrons (from atomic
valence shell electrons), amino-acid polarity/polarizabil-
ity and amino-acid contact interactions with aqueous
shells (when the amino-acids are exposed to water). The
amino-acid Hydrophobicity values are given in Table 1.
A Cross-CoDependancy (CCD) analysis of amino-
acid electronic and hydrophobicity in proteins detects
whether or not the primary sequence of a given pro-
tein will have dominant and characteristic ISM fre-
quencies for EIIP encoding and Hydrophobicity
encoding that will have intersecting sequence “hot
spots” that define important long range QM/EM di-
pole attraction sites and/or binding epitopes. If co-
dependent hot spots exist in a given protein, then the
periodic physico-chemical properties reflected by the
EIIP and Hydrophobicity indices are basically in
“phase.” The protein sequence hot spots are recovered
by the standard positional ISM Signal to Noise ratio
(S/N) analysis as illustrated in the results section of
this paper [43].
The CCD-DFT analysis utilizes the Euler formula to
strip out the frequency amplitudes:
eiθ ¼ cos θð Þ þ i sin θð Þ ð3Þ
The Euler formula is at the heart of the DFT method,
where an exponential function is related to the sum of
two sinusoidal functions. In this decomposition relation-
ship, cos(Ɵ) represents the amplitude and sin(Ɵ) reflects
the phase of the “time” varying “signal.” Here the phase
angle theta (Ɵ) is equal to 2π*(n/N) at each sliding
window location m where these variables have the same
definition as the equation (1) variables. The CCD-DFT
will only utilize the amplitude portion of the protein
primary sequence signal as reflected by:
Dc m; nð Þ ¼ EIIP  Hydrophobicity  cos θð Þ ð4Þ
Similar to the way the ISM S/N analysis proceeds, the
CCD-DFT analysis computes successive CCD-DFT’s for
sliding fixed width windows of the secondary scale. The
Table 1 The Hydrophobicity proclivity values used in hybrid
algorithm to encode the amino acids
Amino acid Hydrophobicity
Phe 0.0688
Leu 0.0579
Ile 0.0349
Met 0.2213
Val 0.1427
Pro 0.7123
Thr 0.6599
Ser 0.7074
Ala 0.4925
Tyr 0.4523
His 0.6763
Gln 0.8692
Asn 0.8350
Lys 0.9651
Asp 0.9157
Glu 0.8974
Cys 0.2650
Trp 0.3403
Arg 0.9091
Gly 0.6582
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amplitudes of the CCD-DFT windows are calculated
using:
Fd nð Þ ¼
XWw
m¼1
Dc m; nð Þ ð5Þ
Where Ww is the CCD-DFT window width that is cal-
culated by selecting the largest of the EIIP or Hydropho-
bicity dominant correlation distances, as calculated from
the reciprocal of the respective dominant ISM frequen-
cies, which is rounded to the nearest integer. We show
later, the Ww calculated for this ISM analysis of the
HCV NS5A protein is 6. The ratio of Ww to the other
correlation distance is expected to result in a ratio value
near an integer (to which it will be rounded), if the
phase relationship between the EIIP signal and the
Hydrophobicity signals are close and one of the signals
is close to a sub-harmonic of the other.
Microsoft Office 2010 Excel was used to calculate and
plot the Fd(n = 0) and Fd(n = 1) series, where each Fd()
is calculated for the sliding window of width Ww. The
number of Fd() values is N - Ww. The Excel trend plot
feature was used to plot the Fd() values. The Excel trend
plot feature does a smooth curve fit of calculated values,
which is related to a second order b-spline smoothing
method. The Fd (n = 1) points result in a sinusoid of
wavelength of 6 amino-acid steps. The Fd(n = 0) repre-
sents a special case where cos(Ɵ) = 1 and Fd(n = 0) is
simply the sum of the Dc = EIIP*Hydrophobicity values
for each sliding window of size Ww. The Fd(n = 0) coef-
ficients represent the outer amplitude envelope of all
sinusoid frequencies within each sliding window. The
Fd(n = 1) plot sinusoid peaks shows the location of each
putative intersection (phase crossing) of the EIIP and
Hydrophobicity metrics (amino-acid sequence physico-
chemical properties), where we also see the Fd(n = 1)
positive peaks touch the Fd(n = 0) amplitude envelope.
Additional confirmatory work was conducted using
standard FFT methods on the NS5A domain I amino
acids for both power (amplitude squared) and phase
coefficients squared [2].
Docking
Docking simulations were done on a HEX Server [44].
For protein-protein docking, using results from the ISM,
interface residues were set from #513 to 551 in Muscar-
ine M3 receptor (structure PDBID 4DAJ) and from #171
to 187 in HCV NS5A protein domain (structure PDBID
3FQQ). The range angles, which determine conform-
ational space of both proteins, with origins in centroids
of residue selections, were set to 45°. The number of
output solutions was set to 100. The solution with best
docking score was selected for further analysis.
Results
Calculation of the cross-spectrum (CS) between M3R
and each protein from the EUHCV database revealed
that maximal amplitudes and signal-to-noise ratio (S/N)
corresponds to the CS relationship between the M3R
and HCV NS5A proteins, and that f(0.158) represents
the common frequency component in IS for these two
proteins using the EIIP scale.
Because of the variability of the NS5A protein, we fur-
ther investigated the IS cross correlation of both the M3R
protein and the NS5A protein from prototype isolates of
different HCV genotypes. As can be seen in results pre-
sented in Fig. 1, the highest S/N values correspond to
HCV genotype 1b.
To identify the epitope of NS5A which would be in-
volved in immunological cross-reactivity, the EIIP based
ISM analysis of this protein from the prototype HCV BK
isolate was performed. The dominant peak in CS of M3R
and NS5A(BK) corresponds to the frequency f(0.158)
(Fig. 2). Computer-assisted screening of NS5A(BK) with
peptides of different lengths revealed that domain encom-
passing residues 171–187, gives an essential contribution
to the information corresponding to the frequency
f(0.158) (Fig. 3). According to the previously reported re-
sults of similar analysis [28–31], it could be concluded
that this domain of NS5A(BK) is responsible for its im-
munological cross-reactivity with M3R.
In order to predict accessibility of the potential signal
epitope at AA 171–187, we performed an ISM analysis
of NS5A(BK) using a high performance, high fidelity
Hydrophobicity scale [3] as a molecular descriptor of
amino acids instead of the EIIP scale (Fig. 4). The dom-
inant peak in this CS corresponds to the frequency
f(0.480), which corresponds to a 1/f correlation distance
of 2.08 AA. There is a secondary peak at f(0.460) with a
Fig. 1 S/N values from the cross-spectra(CS) of M3R and prototype
NS5A HCV sequences from EUHCV database
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S/N amplitude near that of the primary peak, having a
1/f correlation distance of 2.2 AA. Since the Beta strand/
sheet periodicity is right at 2.2 AA, these two peaks sug-
gest that the NS5A Domain I has secondary structure
that is dominant in Beta sheets, as the Domain I X-Ray
crystal structure confirms (Fig. 7). The EIIP dominant
peak f(0.158) has a 1/f correlation distance of 6.33 AA.
The ratio of the EIIP to the hydrophobicity scale correl-
ation distances yields a ratio of 3, which indicates that
the EIIP scale dominant frequency in Domain I is a sub-
harmonic of the Hydrophobicity dominant frequency.
This relationship implies a pattern essential to the Do-
main I structure and function.
The supplementary FFT analysis (length of 256) of
the encoded domain I amino acids using the EIIP,
hydrophobicity and joint (multiplied) scales generally
confirms these primary functional wavelengths. Inter-
estingly, the squared phase coefficient spectrum of
the joint scale had two primary wavelengths of 2.15
as opposed to 2.08 and 6.24 as opposed to 6.33.
These latter wavelength results are essentially the
same as the native ISM method findings within the
wavelength resolutions imposed by these basic DSP
methods.
The computer-assisted scanning of NS5A(BK) showed
that overlapping domains 172–188 and 175–191 give
the biggest contribution to the dominant frequency
f(0.480) in the IS based on the Hydrophobicity scale [3]
values of amino acids (Fig. 5), which overlap the primary
epitope indicated by the EIIP ISM results. These two
bands also correspond to two signal epitope patterns
(valleys dipping below 0.15) revealed in the CCD-DFT
Fig. 2 Cross-spectrum (CS) of M3R and NS5A(BK)
Fig. 3 Mapping of the domains with maximal contribution to
the frequency component F(0.158) in the informational spectrum
of NS5A(BK)
Fig. 4 Cross-spectrum (CS) of M3R and NS5A(BK)
(Hydrophobicity scale)
Fig. 5 Mapping of the domains with maximal contribution to the
frequency component F(0.480) in the informational spectrum of
NS5A(BK) (Hydrophobicity scale)
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analysis (Fig. 7) with a primary minima at AA 174 and
secondary minima at AA 187, respectively.
It is important to note that the locations of the pri-
mary signal epitope, obtained by both the EIIP and
hydrophobicity [3] scales/descriptors, significantly over-
lap (Fig. 6).
The plot (Fig. 6) represents a Discrete Fourier Trans-
form (DFT) analysis (6 amino-acid sliding window) of
the HCV NS5A protein Domain I, using a convolving
(sliding multiplication) of the EIIP value and the Hydro-
phobicity value for each amino-acid selected (31–207)
from Domain I. A sliding window of 6 AA was chosen
for the analysis owing to the fact that the EIIP dominant
IS 1/f correlation distance is 6.3 AA. The amino-acids
selected from Domain I are those from the Domain I X-
Ray crystal structure in the PDB (3fqq, Fig. 7), which is
the only portion of the HCV NS5A protein with a solved
structure in the PDB. The EIIP and Hydrophobicity
product forces a synchronization between the two met-
rics for the CCD-DFT analysis, but it also reflects im-
portant structural and functional relationships within
the NS5A Domain I amino acids.
In particular, the pronounced valley’s in the blue Fd(0)
trace dipping below 0.15 represent important regions of
phase synchronization between the electronic (EIIP)
configuration and the residue hydrophobicity’s, which
reflect solvent like residue-residue contacts (senso-lato)
and/or important residue contacts with the solvent
(water, senso-stricto). The lowest hydrophobicity values
represent the most hydrophobic residues, which then
range up to higher values near one representing polar
and then ionic residues. Hydrophobicity in the sense of
the Hydrophobicity scale means that the hydrophobic
residue contact with water promotes water-water surface
film/membrane (clathrate) interactions. The Hydropho-
bicity scale also reflects information from the mass,
volume, surface area, secondary group geometry and en-
tropy of the 20 natural amino acids [3].
Further insight into the plot above may be gleaned
from Table 2 below, with notes reflecting both back-
ground information and specific observations from the
CCD-DFT plot, which nails the primary epitope pattern
of the NS5A protein domain #1 at around residue 174
(or 171–182 from the valley width), which is consistent
with the primary ISM result. There may be as many as
6–8 signaling/binding epitopes within Domain I of the
NS5A protein, with significant size Fd(0) valleys, dipping
below 0.15, in the Fig. 6 plot. This pattern is also seen in
the similar number of peaks shown in the amplitude
plots (Figs. 3 and 5). The CCD-DFT analysis not only
confirms the ISM result, but adds further insight into
the structural and functional features of the NS5A pro-
tein domain I. A description of the location and effective
range of the Fd(0) values in the Fig. 6 plot is in the
Table 2 below.
The NS5A domain #1 crystal structure (Fig. 7, PDBe
3fqq) shows the secondary structure is almost all beta
sheets. The valleys in Fd(0) represent distinct and func-
tionally active correlations between EIIP and the Hydro-
phobicity. Position #175 represents the epicenter of the
domain #1 primary epitope, as this is the minimum Fd(0)
amplitude valley. Position #198 on represents a radical
shift in the amino-acid pattern signaling the end of do-
main #1. Positions 174–178 are a Beta strand (TFLV) and
positions 180–183 are a Beta strand. These 2 strands are
part of a 3 strand Beta sheet with a small intercalated
alpha helix. The bound Zinc (Zn + 2) ion is located right
at the alpha helix in the primary epitope area. The puta-
tive epitopes reported in Table 2 are consistent with re-
ported literature epitopes within NS5A, and in particular
the primary NS5A epitope has been reported as a NS5A
dimer binding site (a 2 x 3 = 6 strand beta sheet), where
the dimer is important for viral replication [45, 46]. In
silico docking studies and site directed mutagenesis bind-
ing studies with a known NS5A activity inhibitor implicate
sensitive AA sites: 21,24,28,30,31,38,54,56,58,62,75,92,93;
Fig. 6 NS5A Domain I CCD-DFT showing the major signaling epitope near AA #175
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where AA# 21&24 are in a membrane anchor alpha helix
and the balance of these AA sites are within epitope
ranges indicated in Table 2 [47].
The primary Domain I signal epitope is located in the
center left of the Fig. 7, which is a motif consisting of a
three strand Beta sheet and a small Alpha helix, and the
primary signal epitope is located on two of the Beta
strands in the indicated motif.
The reported domains of the muscarinic M3 receptor
and NS5A that showed compatibility based on the
hydrophobicity spectrums are presented on Fig. 8.
The domains are drawn in stick and colored in orange
and green, respectively. We have also performed rigid
protein – protein docking, targeting proposed domains,
using pdb structures 3FQQ [48] and 4DAJ [49]. The
docking results (Figs. 8, 9, 10 and 11) gave a compatible
solution (among the best ten confirmations), showing
established hydrophobic interactions between domains
of two proteins.
The interactions are presented in Fig. 8 and quantified
in Table 3. Although the indicated interactions are not
completely within the primary predicted region of the
primary epitope, the established hydrophobic interac-
tions are enough close to validate our assumption possi-
bility of interaction between HCV NS5A with M3R.
Moreover, as we compare the contacts in Table 3 with
the epitopes noted in Table 2, we see that all of the con-
tacts recovered in the contact analysis derive from
amino-acids within either the primary epitope or within
two secondary epitopes of the NS5A domain I.
Finally, to determine domain which gives essential
contribution to the information represented by the fre-
quency F(0.158) in MR3, the ISM computer-assisted
screening of the MR3 primary structure was performed.
Identified domain denoted VINM3R is within the C-
terminus of MR3, encompassing the third extracellular
loop (ECL3) and the TM alpha helix #7 (residues 517–
551). According to the ISM concept, this region would
be immunologically crossreactive with NS5 or could be
involved in the direct M3R/NS5A interaction.
Discussion
DSP applications of the EIIP and hydrophobicity scales &
experimental support
The ISM has been successfully applied in structure-
function analysis of many different protein and DNA se-
quences, prediction of biological function of novel proteins,
de novo design of biologically active peptides, assessment
of biological effects of mutations, and identification of new
therapeutic targets [36, 42].
For example a ISM DSP analysis using the EIIP scale
could find known binding sites (hot spots) for 5 chemo-
therapeutic Tubulin binding agents and could also deter-
mine relative differences in binding affinities to these
hot spots as applied to 10 human tubulin isotypes [50].
Similarly, a FFT power spectrum analysis of anti-
microbial peptides found distinct and matching peaks in
power spectra using hydrophobicity as the primary scale
(Kyte & Doolittle hydropathy index) and confirmed with
a composite scale with 4 other AA metrics [51].
An ISM like DFT method has been published [2]
where hydrophobicity and EIIP were found to be es-
pecially robust AA physico-chemical scales (with 611
physico-chemical scales evaluated) for analyzing Influ-
enza A strain proteins with identification of charac-
teristic frequencies as found with the ISM DSP
methods in this study. The ISM like DFT methods showed
that the phase (sin()) coefficients squared spectrum was
Table 2 A list of the NS5A domain I epitopes indicated by the
CCD-DFT analysis
Fd(0) valley (AA#) minima Putative width of epitope effect range (#AA)
about the epitope valley minima
32 (end of N terminal membrane anchor motif)
42 10
66 24
90 24
115 25
144 29
175 31
187 12
Fig. 7 Ribbion diagram of PDBe 3fqq, which is the crystal structure
of Domain I of the NS5A protein
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Fig. 9 The NS5A protein with marked 171–187 region, with amino-
acids drawn in green stick
Fig. 10 The docked conformation of M3 and NS5A, with established
hydrophobic contacts
Fig. 8 The muscarinic M3 receptor (3FQQ) with marked 513–551 region
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generally as informative for finding characteristic frequen-
cies as was the power spectrum [2].
A DSP method has also been developed [1, 52] using a
different algorithm than DFT derived methods, such as
the ISM, using primary protein sequences encoded with
a simple modified Nozaki–Tanford–Zimmerman hydro-
phobicity scale. This DSP method attempted to find
“autocorrelation waves” or “hydrophobic eigenmodes,”
using a lagged auto-covariance matrix decomposition
and all poles power spectral and wavelet transformation.
In practice this method finds characteristic structural/
functional frequencies similar to the ISM method. This
method was applied to Type I Tyrosine Kinase-coupled
receptors and GPCR receptor proteins giving primary
(often structural, such as in GPCR’s 7 transmembrane
alpha helices) and secondary hydrophobicity activity
wavelengths, that were then used to efficiently design
(30 %–80 % hit rate) receptor agonist/antagonist bind-
ing peptides (aptamers, 8–20 residues) against these re-
ceptors (external loops), possessing matching inverted
hydrophobicity structural modes. These results were
confirmed in vivo, both at cellular and organismal
levels (rat).
This same lagged eigen-function method was used to
design aptamers against a globular protein (beta-galactosi-
dase) and verified with temperature dependent kinetic
studies with an ELISA method and the with Van't Hoff re-
lation. The results indicated a classical linear free energy
Fig. 11 Detailed established hydrophobic interactions between M3 and NS5A. Amino-acid residues of proposed region in M3 are colored in
orange; in NS5A are in green. The rest are colored in grey, although not in proposed regions, but with established hydrophobic interactions
Table 3 Hydrophobic contacts between muscarinic M3 receptor and NS5A, with corresponding amino-acid residues, highlighted
atoms and distances and angles between them
Muscarinic M3 receptor (atom) NS5A (atom) Distance/Å Bond angles/degrees (atoms)
ILE 70 (CB) PHE 127 (CG-CD1-CD2-CE1-CE2-CZ
centroid)
3.668 31.747 (ILE70 (CB)—PHE127 (centroid)—PHE
127 (CD1))
TYR 524 (CG-CD1-CD2-CE1-CE2-CZ
centroid)
CYS 190 (SG) 4.601 21.30 (TYR 254 CZ-TYR 254 centroid—CYS
190(SG))
LEU 527 (CG) PRO 189 (CB-CG-CD centroid) 5.244 133.20 (LEU 527(CG)—PRO 189(CA)—PRO
189(centroid)
ILE 534 (CG) LEU 183 (CG) 4.326 48.88 ILE 534 (CG)—LEU 183 (CD2)—LEU
183(CG)
ILE 508 (CG) LEU 179 (CG) 4.994 72.54 ILE 508 (CG)—LEU 179 (CD2)—LEU
179 (CG)
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(enthalpy, entropy) relation characteristic of hydrophobic
interactions of small and large bio-molecules in water.
There was an entropy–enthalpy compensation relation-
ship which showed signs of both competitive and non-
competitive interactions [1].
Some of the references to studies using DSP methods
to analyze protein primary structure using hydrophobi-
city scales and the EIIP scale illustrate the power of ana-
lyzing protein structure and function with these DSP
methods, such as the ISM platform, are far more than
mathematical curiosities’, but rather have experimentally
supported real world applications.
Implications for clinical research
The pathophysiological overlapping between SS and HCV,
presence of anti-M3R antibodies in SS, the role that M3R
plays in the regulation of the heart rate and cardiac repo-
larization [18, 20–22], has led to the assumption that
cardiovagal dysfunction in HCV patients is caused by
anti-M3R antibodies elicited by HCV proteins, or by their
direct interaction with M3R. In order to identify the HCV
protein which possibly is cross-reactive with M3R, or
which binds to this receptor, we performed an ISM ana-
lysis of the HCV proteome. Our analysis has revealed that
the NS5A protein represents the possible interactor with
the M3R receptor, or that this viral protein elicits
antibodies which modulate function of this receptor.
Comparison of the ISM of NS5A from different HCV
genotypes showed that genotype 1 has the highest value
of S/N on the frequency f(0.158) suggesting that these
proteins are the most probable HCV pathological mod-
ulators of the biological activity of M3R (Fig. 1).
Computer-assisted screening revealed that domains
VINNS5A (residues 171–187) and VINM3R (residues
517–551) are probably involved in immunological
cross-reactivity or in direct interaction between NS5A
and M3R. The VINM3R peptide corresponds to part of
the extracellular loop 3 and the TM alpha helix #7.
Informational similarity could result in immunological
cross-reactivity which was experimentally shown in pre-
vious studies [29]. In the current study we have identi-
fied AA 171–187 of the HCV NS5A as the domain
contributing the most to the characteristic information
important for cross-reactivity. Evidence from various
studies carried out with NS5-derived antigens has dem-
onstrated that they are not as immune-reactive as the
other antigens [53, 54], and could be less specific [55].
In contrast to earlier findings, Rodríguez-López et al.
[56], we have found the NS5A domain I region to be
among the most immunogenic. In accordance with the
present results, in their experiments studying the im-
munogenicity of the variable regions of HCV proteins by
ELISA using synthetic peptides from 120 variable re-
gions in sera from HCV-infected cells, they have found
the primary epitope, mapped to region 2144–2149 (172–
177 NS5A) inside the ISM identified NS5A domain I
with the motif (2144) DVTFQV (2149). This finding
provides further support for our hypothesis of NS5A as
possible immunogenic epitope.
Another important data is that ISM identified domain
VINM3R in M3R is overlapping with functional epitopes
of M3R reported by Koo et al. [57] (residues 517–527)
and Tsuboi et al. [58] (residues 517–530) within the M3
third extracellular loop which interacts with autoanti-
bodies from SS patients. This finding suggest that it can-
not be excluded that this antibodies could be also
elicited against NS5A in SS patients infected with HCV,
supporting the finding of an involvement of HCV in the
development of SS in a specific subset of patients [59].
Data from the literature support a link between anti-
bodies against M3R and functional inhibition of the
M3R receptor. The agonist binding site occupation by
antibodies against M3R was reported as the key mechan-
ism for loss of M3R function [60] and new evidence on
the role of antibodies against M3R in M3R internaliza-
tion has been presented [61]. Also it should not be ig-
nored that the TM alpha helix #7 has been reported [49]
as an important allosteric binding site and consequen-
tially a chance exists that an impaired function of M3R
could be mediated through allosteric inhibition by anti-
bodies against M3R.
Another possibility according to the ISM results is dir-
ect interaction between NS5A and M3R. Based on ISM
and protein-protein docking results, we propose that, in
conditions of a water medium, there is possibility that
those two proteins interact and form a complex, like that
of an antigen-antibody. The stabilization is based on
hydrophobic interactions of targeted regions, which are
favored in the water medium. NS5A can act as potential
inhibitor of M3R, or could result in impaired trafficking
of the M3R to the cell surface. In order to test all these
hypothesis and potential molecular mechanisms of
NS5A and M3 interaction, experimental studies can be
designed with guidance from our DSP analysis. These
experimental data should put novel light on the subject
of progenitor hepatic cell apoptosis and the phenomena
of HCV overlap with Sjöngren syndrome [5], or para-
sympathetic lesion [11].
Finally, the N-terminal of M3R region, which was
identified as the region contributing the most to the
characteristic f(0.158) frequency, could be the region of
special interest for the pharmacological design of the
substances that could block cross-reaction with M3R
[30, 31], and in this way preventing cardiac dysautonomy
and M3R dependent hepatocellular damage in HCV pa-
tients. It is also plausible that the mutations in this re-
gion or in other regions that cause the conformational
changes of M3R could induce protective or susceptibility
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effects for different extra-hepatic manifestations of HCV
caused by the lesion of M3R.
Conclusions
In conclusion, our present study could have important
clinical implications, such as the possibility of designing
of aptamer peptides to sequester viral proteins in order
to preclude cellular receptor binding and resulting in
aptamer peptide-protein complexes that could be
cleared by the immune system. Presented advances in
the ISM platform could empower DSP methods to be-
come mainstream tools for analyzing protein structure/
function and to bring about a foundation for better
therapeutics.
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